Iqbal S - Search Results

1

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.

Ramanathan RK, Belani CP, Singh DA, Tanaka M, Lenz HJ, Yen Y, Kindler HL, Iqbal S, Longmate J, Mack PC, Lurje G, Gandour-Edwards R, Dancey J, Gandara DR. Ramanathan RK, et al. Among authors: iqbal s. Cancer Chemother Pharmacol. 2009 Sep;64(4):777-83. doi: 10.1007/s00280-009-0927-7. Epub 2009 Jan 24. Cancer Chemother Pharmacol. 2009. PMID: 19169683 Clinical Trial.

2

Determinants of prognosis and response to therapy in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Curr Oncol Rep. 2001 Mar;3(2):102-8. doi: 10.1007/s11912-001-0008-5. Curr Oncol Rep. 2001. PMID: 11177741 Review.

3

Molecular predictors of treatment and outcome in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Curr Gastroenterol Rep. 2003 Oct;5(5):399-405. doi: 10.1007/s11894-003-0053-3. Curr Gastroenterol Rep. 2003. PMID: 12959721 Review.

4

Integration of novel agents in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S32-9. doi: 10.1007/s00280-004-0884-0. Cancer Chemother Pharmacol. 2004. PMID: 15309512 Review.

5

Tailored chemotherapy for colorectal cancer: a new approach to therapy.

Iqbal S, Stoehlmacher J, Lenz HJ. Iqbal S, et al. Cancer Invest. 2004;22(5):762-73. doi: 10.1081/cnv-200032774. Cancer Invest. 2004. PMID: 15581057 Review.

6

Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Expert Rev Anticancer Ther. 2004 Dec;4(6):947-55. doi: 10.1586/14737140.4.6.947. Expert Rev Anticancer Ther. 2004. PMID: 15606325 Review.

7

Angiogenesis inhibitors in the treatment of colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Semin Oncol. 2004 Dec;31(6 Suppl 17):10-6. doi: 10.1053/j.seminoncol.2004.11.029. Semin Oncol. 2004. PMID: 15696025 Review.

8

Phase I clinical and pharmacokinetic trial of docetaxel and irinotecan administered on a weekly schedule.

Garcia AA, Pujari M, Jeffers S, Iqbal S, Lenz HJ, Beringer P, Louie S. Garcia AA, et al. Among authors: iqbal s. Cancer Chemother Pharmacol. 2005 Jul;56(1):75-82. doi: 10.1007/s00280-004-0940-9. Epub 2005 Apr 5. Cancer Chemother Pharmacol. 2005. PMID: 15809878 Clinical Trial.

9

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Vallböhmer D, et al. Among authors: iqbal s. J Clin Oncol. 2005 May 20;23(15):3536-44. doi: 10.1200/JCO.2005.09.100. J Clin Oncol. 2005. PMID: 15908664

10

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

Gordon MA, Gil J, Lu B, Zhang W, Yang D, Yun J, Schneider S, Groshen S, Iqbal S, Press OA, Rhodes K, Lenz HJ. Gordon MA, et al. Among authors: iqbal s. Pharmacogenomics. 2006 Jan;7(1):67-88. doi: 10.2217/14622416.7.1.67. Pharmacogenomics. 2006. PMID: 16354126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,111 results

Search Page

Filters